arrow
J

John R. Teerlink

university of california san francisco
H指数:86
被引数:3.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Low-Normal Hemoglobin Concentrations and Clinical Outcomes in Heart Failure

低正常血红蛋白浓度与心力衰竭的临床结局

2026-08-280
PRE
Clinical profiles and prognostic impact of residual intravascular and tissue congestion in acute heart failure

急性心力衰竭患者残留的血管内和组织淤血的临床特征及预后影响

2025-11-010
OAAI
Impact of Mild and Moderate Aortic Stenosis in Acute Heart Failure: Insights from RELAX-AHF-2

轻度及中度主动脉瓣狭窄对急性心力衰竭的影响:RELAX-AHF-2研究的启示

2025-09-010
OAAI
Healthcare system deficiencies should never be employed as justification for delivering sub-standard care to heart failure patients. Letter regarding the article ‘Serial assessment of left ventricular ejection fraction for the management of heart failure: Unnecessary and unrealistic?’

医疗体系缺陷绝不应作为向心力衰竭患者提供低于标准护理的借口。关于文章“心力衰竭管理中左心室射血分数的系列评估:不必要且不切实际?”的来信。

2025-08-150
PREAI
Serum magnesium and outcomes in heart failure with reduced ejection fraction: the GALACTIC-HF trial

血清镁与射血分数降低的心力衰竭的结局:GALACTIC-HF试验

2025-08-011
OAAI
The use of left ventricular ejection fraction in the diagnosis and management of heart failure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS)

左心室射血分数在心力衰竭诊断和管理中的应用。欧洲心脏病学会(ESC)心力衰竭协会(HFA)、美国心力衰竭学会(HFSA)和日本心力衰竭学会(JHFS)的临床共识声明。

2025-04-220
PREAI
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Preserved Trial

比较研究者报告与中心裁定心力衰竭结局的EMPEROR-Preserved试验

2025-01-011
PRE
ExCITe: A Narrative Review of Motivating Factors for Residency and Fellowship Selection to Provide Insights Regarding the Waning Interest in Advanced Heart Failure and Transplant Cardiology Training

ExCITe:关于住院医师和专科医师选拔动机因素的叙事综述,旨在为人们对高级心力衰竭和移植心脏病学培训兴趣减弱的问题提供见解。

2024-11-010
PRE
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE
2024-07-092
PRE
Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study
2024-06-010
PRE
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial
2024-04-045
OA